EIR Amphastar Pharmaceuticals Apr 2008

Lilly Barton FDA, Sonya Karsik FDA$595.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observation (via FDA 483) on 09 Apr 2008.

Product details

  • Category:
  • Inspection end: 09 Apr 2008
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart